Analysis of Other Confounding Factors Is Mandatory before Considering That Long-Acting Erythropoiesis Stimulating Agents Are Deleterious to Patients on Dialysis.

Rostoker, Guy; Lepeytre, Fanny; Rottembourg, Jacques

Rostoker, Guy; Lepeytre, Fanny; Rottembourg, Jacques.

Afiliación

Rostoker G; Division of Nephrology and Dialysis, Ramsay Générale de Santé, Claude Galien Hospital, Quincy-sous-Sénart, France; and rostotom@orange.fr.
Lepeytre F; Division of Nephrology and Dialysis, Ramsay Générale de Santé, Claude Galien Hospital, Quincy-sous-Sénart, France; and.
Rottembourg J; Division of Nephrology, Dialysis and Transplantation, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris, France.

J Am Soc Nephrol ; 30(9): 1771, 2019 09.

Article en En | MEDLINE | ID: mdl-31420408

Asunto(s)

Eritropoyetina; Hematínicos; Epoetina alfa; Humanos; Diálisis Renal

Palabras clave

anemia; chronic hemodialysis; erythropoietin; hemodialysis hazards; mortality risk

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Eritropoyetina / Hematínicos Límite: Humans Idioma: En Revista: J Am Soc Nephrol Asunto de la revista: NEFROLOGIA Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google